Not Medicine, but a Trade in Poison: A Threat to India’s Global Reputation
Lalit Gargg
Recent revelations have caused deep concern and anxiety across the country after it emerged that several life-saving and commonly used medicines failed to meet quality standards. In the drug alert issued by the Central Drugs Standard Control Organization, samples of medicines used for heart disease, high blood pressure, diabetes, epilepsy, infections, vitamin supplements, and cough syrups were found substandard. This is not merely an administrative lapse; it is a dangerous assault on human life that has raised serious questions about the nation’s healthcare safety system. A medicine that a patient buys in the hope of survival turning into poison inside the body is not only a failure of the medical system, but the ultimate collapse of human sensitivity and ethics.
Ironically, India already has strict rules, inspections, and testing mechanisms for the manufacture and distribution of medicines. From the quality of raw materials to production processes, multiple layers of scrutiny exist. Yet when medicines produced by reputed companies fail quality standards, it becomes evident that the blind race for profit has crushed morality and humanity. This is not merely an economic offense; it is a crime against humanity. Tragically, those entrusted with safeguarding human life are themselves endangering it for selfish gain. India today is among the world’s largest pharmaceutical producers. Indian medicines are exported to America, Europe, Africa, Asia, and the Middle East. India has earned the title of the “Pharmacy of the World” because of its vital role in supplying affordable and effective medicines globally. During the COVID-19 pandemic, India strengthened its global credibility and humanitarian image by supplying vaccines and essential medicines worldwide. Yet the recent exposure of substandard medicines has severely dented that reputation.
The states where poor-quality medicines were reportedly manufactured include Himachal Pradesh, Uttarakhand, Gujarat, Punjab, Rajasthan, Uttar Pradesh, Madhya Pradesh, Haryana, Tamil Nadu, Maharashtra, Kerala, Puducherry, Telangana, Sikkim, Jharkhand, Delhi, West Bengal, Andhra Pradesh, Odisha, and others. This indicates that the problem is not isolated to one or two states; rather, it reflects a deeply widespread crisis. One may say that not just a part, but the entire system appears tainted. Most alarming is the fact that 17 samples of cough syrups failed quality tests. This revelation strengthens earlier allegations made in some African and Central Asian countries, where children reportedly died after consuming Indian-manufactured cough syrups. Those accusations, once dismissed, now appear disturbingly credible, tarnishing the image of India’s pharmaceutical industry across the globe.
These developments come at a time when India is rapidly advancing toward becoming a developed nation. Under the leadership of Narendra Modi, the country is striving to achieve the vision of a “Developed India” by 2047, marking 100 years of independence. India is moving toward becoming the world’s third-largest economy. Through initiatives like Digital India, Make in India, Atmanirbhar Bharat, and reforms in healthcare, the nation seeks global leadership. However, the dream of making India a “Vishwaguru” cannot rest solely on economic growth; it must also stand on the pillars of morality, quality, and trustworthiness. If life-saving medicines themselves become symbols of adulteration and negligence, it stains all positive national efforts.
The need of the hour is for the government to strengthen the drug regulatory system further. Formal inspections and periodic drug alerts are no longer enough. Manufacturing units must undergo regular and transparent inspections. Companies repeatedly failing quality standards should have their licenses cancelled immediately, along with strict punitive action. Special campaigns must be launched against drug mafias and counterfeit medicine networks. Punishment should not be limited to financial penalties alone; harsh imprisonment must also be imposed to create a strong deterrent. Another serious concern is that state governments and regulatory agencies often appear reluctant to act against influential pharmaceutical companies. Financial power and political influence slow down investigations, and ultimately ordinary citizens pay the price. Such a situation is dangerous both for democratic governance and administrative accountability.
Patients consume medicines with the hope of recovery. But what must they feel when they discover that the medicines they trusted are, in reality, poison circulating in the market? Today, countless people in India are not being saved by medicines but are instead being harmed by them. Human greed and selfishness are killing human beings. Those who play with people’s lives in the name of healthcare can rightly be called demons of modern society, spreading death under the guise of treatment. Many reputed pharmaceutical companies have also been found associated with substandard medicines. The pharmaceutical industry is not merely a business; it is an industry built on trust. Ethics should hold the highest place here. Unfortunately, greed and profiteering have now penetrated this field deeply. Fake injections, adulterated medicines, repackaging of expired drugs, and the use of inferior raw materials reveal how social sensitivity and moral consciousness are rapidly eroding. Human beings have become willing to gamble with others’ lives for personal gain. This is not just a legal issue but a sign of profound social and moral decline.
Public awareness regarding medicines is equally important. Consumers must insist on bills while purchasing medicines, verify packaging and manufacturing dates, report suspicious drugs to authorities, and avoid consuming medicines without proper medical advice. These may appear to be small precautions, but they are crucial. Medical stores must also be monitored regularly to prevent the sale of counterfeit or poor-quality medicines. Tampering with the quality of medicines exposes the cruel and inhuman face of certain pharmaceutical manufacturers who are destroying human health. On one hand, diseases continue to rise without effective cures; on the other, even essential medicines have been compromised by greed-driven individuals. Increasing illnesses are becoming uncontrollable because of such unethical practices. Governments too have often failed to control these tragic conditions. Millions of citizens look helplessly toward the administration, hoping for a solution.
India today stands at a decisive crossroads. On one side, the nation is reaching new heights; on the other, such tragic and shameful incidents expose our moral and administrative weaknesses. If India truly wishes to become a developed and trustworthy nation, then alongside economic progress it must place the highest priority on quality, integrity, and human values. Adulteration in life-saving medicines is not merely a healthcare crisis; it is a stain on the soul of the nation. This is a time for deep introspection. The government, pharmaceutical industry, medical fraternity, and society must collectively ensure that medicines remain a means of saving lives—not a business of death. Only then will the dream of a truly developed India acquire genuine meaning.
साभार :
© CopyRight Pressnote.in | A Avid Web Solutions Venture.